Earnings report for Milestone Pharmaceuticals Inc. (MIST) expected on March 19. Analysts predict 16 cents per share on $1.20M revenue. Latest Ratings for MIST DateFirmActionFromTo

Galaxy Digital’s Will Owens says most crypto wallets are not vulnerable to quantum computing risks, and substantial work is being done to address the threat.

Treasury Sec. Scott Bessent rejects oil futures intervention rumors, using a temporary Russian oil sanctions waiver to tame the energy shock. Importance Rank:  1 read

BioLineRx Ltd. (NASDAQ: BLRX) to release Q4 earnings on March 23. Previous Q3 losses were 22 cents per share, with sales of $427,000. Analysts rate

The CNN Money Fear and Greed index shows easing fear levels but remains in the ‘Extreme Fear’ zone on Thursday. Importance Rank:  1 read more